东西方肝癌的分析比较.pptxVIP

东西方肝癌的分析比较第1页/共43页 Geographic and ethnic factors become important in the era of molecular targeted therapy for cancers第2页/共43页 Asian (n=342)Non-Asian (n=1350)Proportion survivingTime (months)0.01.00.202468101214160246810121416GefitinibPlaceboImportance of Ethnicity for MTA ─ the lessons of ISEL trial第3页/共43页 EGFR mutation rates in each subgroupStudyCentreNo. of patientsAdenoCa(+BAC) (%)M (%)F (%)Smokers (%)n-smokers (%)Taiwan1NTUH624925612956Taiwan2VGH-T3767.452724469Korea3Seoul NU90219331326Japan4NCC Tokyo666153693568Japan5Aichi CCH596444704271HK6Chinese U7232————China7Pek UMCH7648.632.334.8